Exelixis, Inc. (EXEL)
42.68
-0.26
(-0.61%)
USD |
NASDAQ |
Feb 12, 16:00
42.70
+0.02
(+0.05%)
After-Hours: 20:00
Exelixis Total Assets (Quarterly) : 2.882B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Natera, Inc. | 1.821B |
| Merck & Co., Inc. | -- |
| Gilead Sciences, Inc. | 59.02B |
| ADMA Biologics, Inc. | 568.69M |
| Axsome Therapeutics, Inc. | 669.25M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 720.71M |
| Shareholders Equity (Quarterly) | 2.161B |
| Debt to Equity Ratio | 0.093 |
| Current Ratio | 3.558 |
| Net Debt Paydown Yield | -0.01% |